Maryam Nakhjavani

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 11

Top Topics

Endothelial Cells

Metastatic Breast Cancer

Molecular Docking

Top Venues

Pharmaceuticals (Basel, Switzerland)

Molecules (Basel, Switzerland)

Journal of breast cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Breanna Giles, Maryam Nakhjavani, Andrew Wiesa, Tareeque Knight, Sarah Shigdar, Rasika M Samarasinghe
Unravelling the Glioblastoma Tumour Microenvironment: Can Aptamer Targeted Delivery Become Successful in Treating Brain Cancers? Cancers 15 (17) (2023)
Maryam Nakhjavani, Sarah Shigdar
Natural Blockers of PD-1/PD-L1 Interaction for the Immunotherapy of Triple-Negative Breast Cancer-Brain Metastasis. Cancers 14 (24) (2022)
Maryam Nakhjavani, Sarah Shigdar
Natural Blockers of PD-1/PD-L1 Interaction for the Immunotherapy of Triple-Negative Breast Cancer-Brain Metastasis. Cancers 14 (24) (2022)
Maryam Nakhjavani, Eric Smith, Kenny Yeo, Helen M Palethorpe, Yoko Tomita, Tim J Price, Amanda R Townsend, Jennifer E Hardingham
Anti-Angiogenic Properties of Ginsenoside Rg3 Epimers: In Vitro Assessment of Single and Combination Treatments. Cancers 13 (9) (2021)
Maryam Nakhjavani, Eric Smith, Helen M Palethorpe, Yoko Tomita, Kenny Yeo, Tim J Price, Amanda R Townsend, Jennifer E Hardingham
Anti-Cancer Effects of an Optimised Combination of Ginsenoside Rg3 Epimers on Triple Negative Breast Cancer Models. Pharmaceuticals (Basel, Switzerland) 14 (7) (2021)
Yoko Tomita, Eric Smith, Helen M Palethorpe, Maryam Nakhjavani, Kenny K L Yeo, Amanda R Townsend, Timothy J Price, Andrea J Yool, Jennifer E Hardingham
In Vitro Synergistic Inhibition of HT-29 Proliferation and 2H-11 and HUVEC Tubulogenesis by Bacopaside I and II Is Associated with Ca2+ Flux and Loss of Plasma Membrane Integrity. Pharmaceuticals (Basel, Switzerland) 14 (5) (2021)
Maryam Nakhjavani, Eric Smith, Amanda R Townsend, Timothy J Price, Jennifer E Hardingham
Anti-Angiogenic Properties of Ginsenoside Rg3. Molecules (Basel, Switzerland) 25 (21) (2020)
Helen M Palethorpe, Eric Smith, Yoko Tomita, Maryam Nakhjavani, Andrea J Yool, Timothy J Price, Joanne P Young, Amanda R Townsend, Jennifer E Hardingham
Bacopasides I and II Act in Synergy to Inhibit the Growth, Migration and Invasion of Breast Cancer Cell Lines. Molecules (Basel, Switzerland) 24 (19) (2019)
Yoko Tomita, Helen M Palethorpe, Eric Smith, Maryam Nakhjavani, Amanda R Townsend, Timothy J Price, Andrea J Yool, Jennifer E Hardingham
Bumetanide-Derived Aquaporin 1 Inhibitors, AqB013 and AqB050 Inhibit Tube Formation of Endothelial Cells through Induction of Apoptosis and Impaired Migration In Vitro. International journal of molecular sciences 20 (8) (2019)
Maryam Nakhjavani, Jennifer E Hardingham, Helen M Palethorpe, Yoko Tomita, Eric Smith, Tim J Price, Amanda R Townsend
Ginsenoside Rg3: Potential Molecular Targets and Therapeutic Indication in Metastatic Breast Cancer. Medicines (Basel, Switzerland) 6 (1) (2019)
Maryam Nakhjavani, Jennifer E Hardingham, Helen M Palethorpe, Timothy Jay Price, Amanda R Townsend
Druggable Molecular Targets for the Treatment of Triple Negative Breast Cancer. Journal of breast cancer 22 (3) (2019)